RecruitingNot ApplicableNCT05842161

South Africa Smoking Cessation and Engagement in HIV/TB Care Care

Treatment Development for Smoking Cessation and Engagement in HIV/TB


Sponsor

Massachusetts General Hospital

Enrollment

86 participants

Start Date

Mar 12, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to integrate elements from existing interventions developed by our team into a single intervention (QUIT-AD), designed to improve smoking cessation and favorable HIV/TB treatment outcomes among individuals with HIV and/or TB in Cape Town, South Africa. If feasibility, acceptability, and preliminary efficacy are demonstrated, the intervention will be ready for large-scale effectiveness/implementation testing. This program will has the potential to dramatically improve public health by increasing the smoking quit rate and facilitating favorable HIV/TB treatment outcomes among patients with HIV and/or TB in resource limited South African settings.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a smoking cessation program for people in South Africa who are living with HIV and/or tuberculosis (TB) and are daily smokers. Smoking makes HIV and TB worse, and helping these patients quit could significantly improve their health outcomes. **You may be eligible if...** - You are 18 or older - You are living with HIV (on antiretroviral therapy) and/or currently being treated for TB - You smoke more than 5 cigarettes per day - You are motivated to quit smoking (scoring 5 or higher out of 10) or have made a quit attempt in the past year **You may NOT be eligible if...** - You regularly use other tobacco products (cigars, pipes, etc.) - You have a serious unstable mental health condition such as active psychosis or bipolar disorder - You are already using nicotine replacement therapy or other quit-smoking medications - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALQUIT-AD

An adapted, six-session cognitive behavioral therapy intervention for smoking cessation and treatment adherence

OTHEREnhanced Treatment as Usual

Standard treatment for HIV/TB with one session of psychoeducation.


Locations(1)

University of Cape Town

Rondebosch, South Africa

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05842161


Related Trials